This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
23 Nov 2011

Pfizer & MIT Break Ground on New Research Units

The company anticipates hiring a significant number of scientists for the two research units, including biologists, chemists and individuals with other areas of research expertise.

Pfizer Inc. and the Massachusetts Institute of Technology recently held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units in Cambridge, MA.

 

In September, Pfizer announced it had entered into a 10-year lease agreement with MIT for more than 180,000 square feet.

 

In February Pfizer announced a strategic shift in research and development, to focus the company's efforts on a smaller number of research areas where the potential for impact is greatest, including its CVMED and Neuroscience research units. As part of this shift, Pfizer announced it would substantially boost its presence in Cambridge by moving these two important research units th

Related News